Cargando…
Second malignancies following conventional or combined (252)Cf neutron brachytherapy with external beam radiotherapy for breast cancer
We retrospectively evaluated the risk of second malignancies among 832 patients with inner or central breast cancer treated with conventional external beam schedule (CRT group), or neutron brachytherapy using Californium-252 ((252)Cf) sources and hypofractionated external beam radiotherapy (HRTC gro...
Autores principales: | Valuckas, Konstantinas Povilas, Atkocius, Vydmantas, Kuzmickiene, Irena, Aleknavicius, Eduardas, Liukpetryte, Sarune, Ostapenko, Valerijus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766283/ https://www.ncbi.nlm.nih.gov/pubmed/23397075 http://dx.doi.org/10.1093/jrr/rrt009 |
Ejemplares similares
-
Californium versus cobalt brachytherapy combined with external-beam radiotherapy for IIB stage cervical cancer: long-term experience of a single institute
por: Janulionis, Ernestas, et al.
Publicado: (2015) -
The value of prognostic factors for uterine cervical cancer patients treated with irradiation alone
por: Grigienė, Rūta, et al.
Publicado: (2007) -
A randomized hypofractionation dose escalation trial for high risk prostate cancer patients: interim analysis of acute toxicity and quality of life in 124 patients
por: Norkus, Darius, et al.
Publicado: (2013) -
A Monte Carlo Study on the Effect of Various Neutron Capturers on Dose Distribution in Brachytherapy with (252)Cf Source
por: Firoozabadi, M.M., et al.
Publicado: (2017) -
Investigation of prompt neutrons accompanying spontaneous ternary fission of $^{252}Cf$
por: Piekarz, H, et al.
Publicado: (1970)